Hanger Orthopedic Group (HGR)
Hanger Orthopedic Group R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these HGR related companies
HGR News
Hanger's Thomas F. Kirk Announces Retirement as CEO; Board Appoints Vinit K. Asar as Successor
May 21, 4:15PM Benzinga
May 21, 4:15PM Benzinga
Listen to $HGR Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3e6F
about 26 days ago by earningscast
about 26 days ago by earningscast
UPDATE: Jefferies Raises PT to $27 on Hanger Orthopedic Group; Strong Q1, WalkAide Progress
May 03, 8:13AM Benzinga
May 03, 8:13AM Benzinga
Hanger Orthopedic Group Reports 15.8% Growth in First Quarter 2012 Diluted EPS to $0.22
May 02, 4:01PM PR Newswire
May 02, 4:01PM PR Newswire
$HGR forms bullish "Ascending Continuation Triangle" chart pattern. http://stks.co/3YvO
about 32 days ago by RecogniaEvents
about 32 days ago by RecogniaEvents
$HGR forms bullish "Head and Shoulders Bottom" chart pattern. http://stks.co/3YvM
about 32 days ago by RecogniaEvents
about 32 days ago by RecogniaEvents
Hanger Orthopedic Group, Inc. Announces First Quarter 2012 Earnings Release Conference Call
Mar 28, 4:54PM PR Newswire
Mar 28, 4:54PM PR Newswire
Listen to $HGR Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2KA4
about 110 days ago by earningscast
about 110 days ago by earningscast
Hanger Orthopedic Group, Inc. (HGR) Tops Q4 EPS by 4c, Offers FY12 Guidance
Feb 08, 5:27PM Street Insider
Feb 08, 5:27PM Street Insider
Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2011 Earnings Release Conference Call
Jan 09, 6:01PM PR Newswire
Jan 09, 6:01PM PR Newswire
Hanger Orthopedic Group, Inc. Announces Appointment of Patricia B. Shrader to Board of Directors
Dec 19, 4:10PM Benzinga
Dec 19, 4:10PM Benzinga
Hanger Orthopedic Group, Inc. Announces Appointment of Patricia B. Shrader to Board of Directors
Dec 19, 4:10PM PR Newswire
Dec 19, 4:10PM PR Newswire
$HGR
Hanger Orthopedic Q2 EPS of $0.45 vs. $0.45 Est; Revenues $234.8M vs. $239.57M Est
about 307 days ago by Benzinga
about 307 days ago by Benzinga
$HGR
Hanger Orthopedic Q2 EPS of $0.45 vs. $0.45 Est; Revenues $234.8M vs. $239.57M Est
about 307 days ago by Benzinga
about 307 days ago by Benzinga
$HGR http://chart.ly/trd2me4 HGR - 100% Barchart technical sell signal - below its 20, 50 and 100 DMA - 17.60% off high
about 362 days ago by jimvanmeerten
about 362 days ago by jimvanmeerten
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HGR | 22.05 | +0.69 | +3.23% | 727.09M |
| HGIC | 59.94 | +0.00 | +0.00% | 1.635B |
| HGI | 15.41 | +0.18 | +1.20% | |
| HGG | 11.09 | +0.22 | +2.02% | 404.80M |
| HGEM | 17.67 | +0.00 | +0.00% | |
| HFWA | 13.77 | +0.34 | +2.53% | 207.76M |
| HFC | 30.34 | +0.00 | +0.00% | 6.318B |
| HFBC | 7.05 | -0.10 | -1.47% | 55.62M |
| HF | 13.16 | +0.00 | +0.00% | 484.81M |
| HERO | 3.76 | +0.07 | +1.90% | 584.64M |
